Tom G Obrig

University Of Virginia Charlottesville

$7,907,950

Attributed

$7,907,950

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.7M · FY2005–09

$2M$1.5M$1M$500K$0

'05

'06

'07

'08

'09

Funding mix

By agency

NIH$7,907,950 · 3

By mechanism

U01$5,055,207 · 2

R01$2,852,743 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Virginia Charlottesville

Same institution · by research overlap

Mark Douglas Okusa$24,807,098
Adrian R Gear$1,628,741
Joel M. Linden$14,399,863
Richard L Guerrant$21,982,423
Roberto Ariel Gomez$14,833,197

Others in their field

Top investigators on “Lipopolysaccharides”

Bruce A Beutler · Ut Southwestern Medical Center$21,787,231
Michael Stephen Trent · University Of Georgia$19,970,261
Daniel E Kahne · Harvard University$19,426,946
Robert O'Conner · Alion Science And Technology Corp$14,945,723
Laura E. Nagy · Case Western Reserve University$14,567,506
Stefanie N. Vogel · University Of Maryland Baltimore$13,942,871

Research focus

LipopolysaccharidesShiga ToxinEscherichia ColiInflammationInterleukin 1Enzyme Linked Immunosorbent AssayLaboratory MouseTumor Necrosis Factor AlphaBacterial DiseaseKidneyVascular EndotheliumBiological Signal TransductionHemolytic-Uremic SyndromeReceptorInflammatoryReceptor ExpressionIn VivoInflammatory ResponseIn VitroKidney DiseasesAgonistImmunocytochemistryCell TypeAnti-Inflammatory Agents